IL165935A0 - Use of vasopeptidase inhibitors in the treatment of nephropathy - Google Patents

Use of vasopeptidase inhibitors in the treatment of nephropathy

Info

Publication number: IL165935A0
Authority: IL; Israel
Prior art keywords: nephropathy; treatment; vasopeptidase inhibitors; vasopeptidase; inhibitors
Prior art date: 2002-06-28

Application number

IL16593503A

Other languages

English (en)

Original Assignee

Aventis Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-06-28

Filing date

2003-06-13

Publication date

2006-01-15

2003-06-13 Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh

2006-01-15 Publication of IL165935A0 publication Critical patent/IL165935A0/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Hematology (AREA)
Obesity (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Ophthalmology & Optometry (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
Endocrinology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Enzymes And Modification Thereof (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

IL16593503A 2002-06-28 2003-06-13 Use of vasopeptidase inhibitors in the treatment of nephropathy IL165935A0 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE2002129180 DE10229180A1 (de)	2002-06-28	2002-06-28	Verwendung von Vasopeptidase-Inhibitoren bei der Behandlung von metabolischen Erkrankungen, Nephropathie und mit AGE assoziierten Erkrankungen

Publications (1)

Publication Number	Publication Date
IL165935A0 true IL165935A0 (en)	2006-01-15

Family

ID=29795983

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL16593503A IL165935A0 (en)	2002-06-28	2003-06-13	Use of vasopeptidase inhibitors in the treatment of nephropathy
IL16593504A IL165935A (en)	2002-06-28	2004-12-22	Vasopeptidase inhibitors

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL16593504A IL165935A (en)	2002-06-28	2004-12-22	Vasopeptidase inhibitors

Country Status (38)

Country	Link
US (2)	US6930103B2 (es)
EP (1)	EP1519732B1 (es)
JP (1)	JP4564354B2 (es)
KR (1)	KR101072235B1 (es)
CN (1)	CN100366254C (es)
AR (1)	AR040343A1 (es)
AT (1)	ATE548040T1 (es)
AU (1)	AU2003280440B2 (es)
BR (1)	BR0312250A (es)
CA (1)	CA2490277C (es)
CR (1)	CR7667A (es)
CY (1)	CY1112905T1 (es)
DE (1)	DE10229180A1 (es)
DK (1)	DK1519732T3 (es)
EC (1)	ECSP045513A (es)
ES (1)	ES2383889T3 (es)
HN (1)	HN2003000193A (es)
HR (1)	HRP20041212B1 (es)
IL (2)	IL165935A0 (es)
MA (1)	MA27281A1 (es)
MX (1)	MXPA04012230A (es)
NO (1)	NO334811B1 (es)
NZ (1)	NZ537480A (es)
OA (1)	OA12871A (es)
PA (1)	PA8576501A1 (es)
PE (1)	PE20040582A1 (es)
PL (1)	PL218070B1 (es)
PT (1)	PT1519732E (es)
RS (1)	RS52478B (es)
RU (1)	RU2336080C2 (es)
SI (1)	SI1519732T1 (es)
SV (1)	SV2004001560A (es)
TN (1)	TNSN04262A1 (es)
TW (1)	TWI326215B (es)
UA (1)	UA82845C2 (es)
UY (1)	UY27869A1 (es)
WO (1)	WO2004002492A1 (es)
ZA (1)	ZA200409382B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2482546C2 (ru) *	2011-04-28	2013-05-20	Общество С Ограниченной Ответственностью "Научно-Производственная Фирма "Материа Медика Холдинг"	Способ коррекции эндотелиальной дисфункции раствором гомеопатических разведений антител к с-концевому фрагменту рецептора ангиотензина ii

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5430145A (en) *	1990-10-18	1995-07-04	Merrell Dow Pharmaceuticals Inc.	Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
CA2053340C (en) *	1990-10-18	2002-04-02	Timothy P. Burkholder	Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
ATE138645T1 (de) *	1991-03-01	1996-06-15	Zeria Pharm Co Ltd	Indan-derivate als thromboxan-antagonisten
RU2098411C1 (ru) *	1991-08-02	1997-12-10	Иституто Лусо Фармако д Италия С.п.А.	Производные пиримидина, способ их получения, фармацевтическая композиция на их основе
ES2106112T3 (es) *	1991-09-27	1997-11-01	Merrell Pharma Inc	Derivados de indano-2-mercaptoacetilamida con una actividad inhibidora de encefalinasa y de ace.
WO1993016103A1 (en) *	1992-02-14	1993-08-19	Merrell Dow Pharmaceuticals Inc.	Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
US5484783A (en) *	1994-03-24	1996-01-16	Merrell Dow Pharmaceuticals Inc.	Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide and benzazapine derivatives
ATE189392T1 (de) *	1994-03-24	2000-02-15	Merrell Pharma Inc	Hypocholesterolemische, antiatherosklerotische und hypotriglyceridemische verwendung von aminoacetylmercapto derivaten
CA2224451A1 (en) *	1995-06-30	1997-01-23	Merck & Co., Inc.	Method of treating renal disease using an ace inhibitor and an aii antagonist
BR9612316A (pt)	1995-12-27	1999-07-13	Yoshitomi Pharmaceutical	Agente para profilaxia e tratamento de complicações diabéticas
RU2276997C2 (ru) *	1999-08-30	2006-05-27	Санофи-Авентис Дойчланд Гмбх	Применение ингибиторов ренин-ангиотензиновой системы для профилактики сердечно-сосудистых явлений
US6149915A (en)	1999-09-29	2000-11-21	Shiva Biomedical, Llc	Treatment of diabetic nephropathy and microalbuminuria
EP1381605B1 (en) *	2001-04-12	2005-01-12	Aventis Pharma Deutschland GmbH	Mercaptoacetylamide derivatives, a process for their preparation and their use
US20030040509A1 (en) *	2001-08-06	2003-02-27	Genomed, Llc	Methods and compositions for treating diseases associated with excesses in ACE

2002
- 2002-06-28 DE DE2002129180 patent/DE10229180A1/de not_active Ceased
2003
- 2003-06-13 JP JP2004516596A patent/JP4564354B2/ja not_active Expired - Fee Related
- 2003-06-13 WO PCT/EP2003/006276 patent/WO2004002492A1/en not_active Ceased
- 2003-06-13 BR BR0312250A patent/BR0312250A/pt not_active IP Right Cessation
- 2003-06-13 IL IL16593503A patent/IL165935A0/xx unknown
- 2003-06-13 UA UA2005000743A patent/UA82845C2/xx unknown
- 2003-06-13 PL PL372992A patent/PL218070B1/pl unknown
- 2003-06-13 AT AT03740247T patent/ATE548040T1/de active
- 2003-06-13 HR HRP20041212AA patent/HRP20041212B1/hr not_active IP Right Cessation
- 2003-06-13 KR KR1020047021259A patent/KR101072235B1/ko not_active Expired - Fee Related
- 2003-06-13 CN CNB038153491A patent/CN100366254C/zh not_active Expired - Fee Related
- 2003-06-13 MX MXPA04012230A patent/MXPA04012230A/es active IP Right Grant
- 2003-06-13 PT PT03740247T patent/PT1519732E/pt unknown
- 2003-06-13 EP EP20030740247 patent/EP1519732B1/en not_active Expired - Lifetime
- 2003-06-13 NZ NZ537480A patent/NZ537480A/en not_active IP Right Cessation
- 2003-06-13 ES ES03740247T patent/ES2383889T3/es not_active Expired - Lifetime
- 2003-06-13 RU RU2005102087A patent/RU2336080C2/ru not_active IP Right Cessation
- 2003-06-13 AU AU2003280440A patent/AU2003280440B2/en not_active Ceased
- 2003-06-13 DK DK03740247T patent/DK1519732T3/da active
- 2003-06-13 RS YUP100704 patent/RS52478B/sr unknown
- 2003-06-13 CA CA 2490277 patent/CA2490277C/en not_active Expired - Fee Related
- 2003-06-13 SI SI200332139T patent/SI1519732T1/sl unknown
- 2003-06-13 OA OA1200400333A patent/OA12871A/en unknown
- 2003-06-20 PE PE2003000623A patent/PE20040582A1/es not_active Application Discontinuation
- 2003-06-23 SV SV2003001560A patent/SV2004001560A/es not_active Application Discontinuation
- 2003-06-24 PA PA8576501A patent/PA8576501A1/es unknown
- 2003-06-26 US US10/607,521 patent/US6930103B2/en not_active Expired - Lifetime
- 2003-06-26 HN HN2003000193A patent/HN2003000193A/es unknown
- 2003-06-26 AR ARP030102293 patent/AR040343A1/es unknown
- 2003-06-26 TW TW92117352A patent/TWI326215B/zh not_active IP Right Cessation
- 2003-06-27 UY UY27869A patent/UY27869A1/es unknown
2004
- 2004-11-22 ZA ZA2004/09382A patent/ZA200409382B/en unknown
- 2004-12-08 MA MA27991A patent/MA27281A1/fr unknown
- 2004-12-22 IL IL16593504A patent/IL165935A/en not_active IP Right Cessation
- 2004-12-27 TN TNP2004000262A patent/TNSN04262A1/en unknown
- 2004-12-27 EC ECSP045513 patent/ECSP045513A/es unknown
2005
- 2005-01-25 NO NO20050425A patent/NO334811B1/no not_active IP Right Cessation
- 2005-01-28 CR CR7667A patent/CR7667A/es unknown
- 2005-04-01 US US11/096,790 patent/US7514423B2/en not_active Expired - Lifetime
2012
- 2012-05-30 CY CY20121100488T patent/CY1112905T1/el unknown

Also Published As

Publication number	Publication date
PA8576501A1 (es)	2004-02-07
SV2004001560A (es)	2004-02-26
DK1519732T3 (da)	2012-06-18
NZ537480A (en)	2005-11-25
TWI326215B (en)	2010-06-21
ECSP045513A (es)	2005-03-10
AR040343A1 (es)	2005-03-30
EP1519732B1 (en)	2012-03-07
RU2005102087A (ru)	2005-07-10
DE10229180A1 (de)	2004-01-29
UY27869A1 (es)	2003-12-31
NO334811B1 (no)	2014-06-02
PL218070B1 (pl)	2014-10-31
CA2490277C (en)	2011-11-01
UA82845C2 (en)	2008-05-26
TW200406214A (en)	2004-05-01
RS52478B (sr)	2013-02-28
BR0312250A (pt)	2005-04-26
KR20050013642A (ko)	2005-02-04
US6930103B2 (en)	2005-08-16
OA12871A (en)	2006-09-15
ATE548040T1 (de)	2012-03-15
CN100366254C (zh)	2008-02-06
PE20040582A1 (es)	2004-10-18
US20050171090A1 (en)	2005-08-04
JP4564354B2 (ja)	2010-10-20
JP2005533815A (ja)	2005-11-10
HRP20041212A2 (en)	2005-06-30
EP1519732A1 (en)	2005-04-06
KR101072235B1 (ko)	2011-10-12
WO2004002492A1 (en)	2004-01-08
HN2003000193A (es)	2004-10-27
IL165935A (en)	2010-12-30
TNSN04262A1 (en)	2007-03-12
ES2383889T3 (es)	2012-06-27
RU2336080C2 (ru)	2008-10-20
AU2003280440A1 (en)	2004-01-19
CN1665512A (zh)	2005-09-07
MXPA04012230A (es)	2005-02-25
CA2490277A1 (en)	2004-01-08
CY1112905T1 (el)	2016-04-13
MA27281A1 (fr)	2005-04-01
CR7667A (es)	2005-06-16
PL372992A1 (en)	2005-08-08
HRP20041212B1 (hr)	2013-06-30
RS100704A (sr)	2007-02-05
NO20050425L (no)	2005-01-25
ZA200409382B (en)	2006-01-25
SI1519732T1 (sl)	2012-05-31
AU2003280440B2 (en)	2009-07-16
HK1079435A1 (zh)	2006-04-07
US20040058911A1 (en)	2004-03-25
US7514423B2 (en)	2009-04-07
PT1519732E (pt)	2012-05-22

Publication	Publication Date	Title
IL166780A0 (en)	2006-01-15	Use of ikappab-kinase inhibitors in pain therapy
AU2003284242A8 (en)	2004-05-04	Methods and compositions for use in treating cancer
AU2003293376A8 (en)	2004-06-30	Anti-angiogenic compounds and their use in cancer treatment
IL178012A0 (en)	2006-12-31	Diphenyl-indol-2-on compounds and their use in the treatment of cancer
IL174994A0 (en)	2006-08-20	Pyrimidin - 4 - yl - 3, 4 - thione compounds and their use in therapy
IL172471A0 (en)	2006-04-10	Gsk-3 inhibitors and uses thereof
AU2003213768A8 (en)	2003-10-13	Use of benzimidazole analogs in the treatment of cell proliferation
AU2003237367A8 (en)	2003-12-19	Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer
AU2003281978A8 (en)	2004-06-18	Compounds for use in treating obesity
HRP20041029A2 (en)	2004-12-31	Therapeutic use of selcetive pde10 inhibitors
AU2003213144A1 (en)	2003-09-09	Alkylating agent combinations in the treatment of cancer
IL172316A0 (en)	2011-08-01	Novel compounds and their use in therapy
GB0324761D0 (en)	2003-11-26	Use of compounds in therapy
PL1917246T3 (pl)	2010-04-30	Pochodne benzochinazoliny i ich zastosowanie do leczenia chorób kości
ZA200410409B (en)	2006-05-31	Use of thio-oxindole derivatives in treatment of hormonerelated conditions
EP1515725A4 (en)	2005-09-21	USE OF CYCLOTHIOCARBAMATE DERIVATIVES IN THE TREATMENT OF HORMONE-RELATED ILLNESSES
AU2003212634A8 (en)	2003-09-22	Compounds useful in the treatment of cancer
AU2003232848A8 (en)	2003-12-31	Phenylaminopyrimidines and their use as rho-kinase inhibitors
IL180138A0 (en)	2007-06-03	2,4,6-trisubstituted pyrimidines as phosphotidylinol (pi) 3-kinase inhibitors and their use in the treatment of cancer
PL374581A1 (en)	2005-10-31	Diaminothiazoles and use thereof as cdk4 inhibitors
GB0207411D0 (en)	2002-05-08	Azole compounds and their therapeutic use
GB0212405D0 (en)	2002-07-10	Composition and its therapeutic use
PL380189A3 (pl)	2007-01-08	Azolidynokarbonitryle i ich zastosowanie jako inhibitory DPP-IV
AU2003206945A8 (en)	2003-09-09	Use of proteinase inhibitors in the treatment of autoimmune diseases
SG110107A1 (en)	2005-04-28	Compound and use in treatment